Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

183
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
183
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

458
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

854
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
854

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic labels and clusters based on oxygen requirements in preterm infants with chronic lung disease: a data-driven exploratory cluster analysis in two independent cohorts.

The Lancet. Child & adolescent health·2025
Same author

Complement-ARIE: Catalyzing the Development and Adoption of New Approach Methodologies.

NAM journal·2025
Same author

Inflammation resolution in environmental pulmonary health and morbidity.

Toxicology and applied pharmacology·2022
Same author

Transcriptomics Underlying Pulmonary Ozone Pathogenesis Regulated by Inflammatory Mediators in Mice.

Antioxidants (Basel, Switzerland)·2021
Same author

Toll-like receptor 4-mediated respiratory syncytial virus disease and lung transcriptomics in differentially susceptible inbred mouse strains.

Physiological genomics·2019
Same author

p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus.

The Journal of clinical investigation·2019

Related Experiment Video

Updated: Jul 12, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K

Countermeasures against Pulmonary Threat Agents.

Jacqui Marzec1, Srikanth Nadadur2

  • 1National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina.

The Journal of Pharmacology and Experimental Therapeutics
|October 20, 2023
PubMed
Summary

Inhaled toxicants, including chemical warfare agents and industrial chemicals, pose significant risks for acute lung injury and long-term respiratory complications. Developing effective countermeasures for mass casualty events is crucial.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

13.9K

Related Experiment Videos

Last Updated: Jul 12, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

13.9K

Area of Science:

  • Environmental Health
  • Toxicology
  • Pulmonary Medicine

Background:

  • Inhaled toxicants, ranging from industrial chemicals to chemical warfare agents (CWAs), are a growing concern due to their potential for severe respiratory complications.
  • Historical and recent use of CWAs, alongside the risks posed by industrial/agricultural chemicals, highlight the need for understanding acute inhalation toxicity.
  • Current emergency treatments are limited to supportive care, emphasizing the need for advanced therapeutic strategies.

Purpose of the Study:

  • To review the current understanding of acute toxicity and pathophysiology of select inhaled chemical threats.
  • To discuss potential early-stage therapeutic developments for lung injury caused by inhaled toxicants.
  • To identify challenges in developing countermeasures for mass casualty situations involving inhaled chemical exposures.

Main Methods:

  • This minireview synthesizes current knowledge on the toxicology and pathophysiology of inhaled toxicants.
  • It examines the clinical progression of lung injury from various chemical exposures.
  • The review discusses existing and potential therapeutic interventions and countermeasure development.

Main Results:

  • Acute exposure to industrial irritants and CWAs can lead to immediate respiratory distress, progressing to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
  • Delayed complications include obstructive lung disease and pulmonary fibrosis, necessitating long-term clinical management.
  • Effective treatments for acute inhalation injury remain limited, underscoring the need for novel therapeutic approaches.

Conclusions:

  • Inhaled chemical threats present a significant and increasing risk in both civilian and military contexts.
  • There is an urgent need to develop effective countermeasures to mitigate acute lung injury and subsequent chronic respiratory conditions.
  • Further research into early-stage therapeutics and mass-administration strategies is essential for addressing these threats.